African Mango 03
Natural health product licensed in Canada
- Other names
- Advanced Formula African Mango, Advanced Formula Mango, Top African Mango Formula, Top Formula African Mango
- Licence holder
- PMK Federal Regulatory Consultants Ltd.
- NPN or DIN-HM
- 80086191
- Status
- Active licence
- Licence date
- 14 June 2018
- Revision date
- 29 October 2020
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Aloe vera (L.) Burm. f.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes et une mention déconseillant l'usage prolongé
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Foeniculum vulgare Mill.: La portion journalière recommandée ne doit pas conduire à une ingestion d'estragole supérieure à 0,05 mg/kg de poids corporel pour les enfants de moins de 12 ans.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Extrait de fève de café vert Source : Graine(s) Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 125 milligramme Potency : 5 % Caffeine | 12.5 milligramme | Not calculated |
| Extrait de fève de café vert Source : Graine(s) Potency : 50 % Chorogenic acids | Not specified | Not calculated |
| Aloe vera Source : Feuille | 0.5 milligramme | Not calculated |
| Frangula alnus Source : Écorce âgée | 0.5 milligramme | Not calculated |
| Foeniculum vulgare subsp. vulgare var. dulce Source : Graine(s) | 0.5 milligramme | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Cellulose microcristalline, Hydroxypropyl méthylcellulose, Aqua
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 1 day |
Uses authorised in Canada
Source of antioxidants.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If you are taking any prescription medication, consult a health care practitioner prior to use (Brinker 2010). If you have diabetes, consult a health care practitioner prior to use. Consult a health care practitioner if symptoms persist or worsen; are taking thiazide diuretics, corticosteroids, licorice root or other medications or health products which may aggravate electrolyte imbalance; have a kidney disorder or are taking cardiac medications such as cardiac glycosides or antiarrhythmic medications; if you have faecal impaction or symptoms such as abdominal pain, nausea, vomiting or fever. Reduce dose or discontinue use if you experience abdominal pain, cramps, spasms and/or diarrhoea.
- Contre-indications
Do not use if pregnant or breastfeeding. Do not use if you have abnormal constrictions of the gastrointestinal tract, potential or existing intestinal blockage, atonic bowel, appendicitis, inflammatory colon disease such as Crohn's disease or ulcerative colitis, abdominal pain of unknown origin, undiagnosed rectal bleeding, severe dehydration with depleted water or electrolytes or diarrhoea. Do not use if you are allergic to anethole or plants of the Apiaceae/Carrot family.
- Effets indésirables connus
If you experience symptoms of hypoglycaemia including feelings of anxiety, dizziness, tremor, sweating, nausea or headache, discontinue use. Hypersensitivity is known to occur, in which case, discontinue use. Discontinue use if hypersensitivity occurs such as skin rash or skin irritation.
Source
Official Health Canada record, licence 80086191
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2020. Photograph the packaging to check whether it has changed. Photograph the packaging